• Exchange: Munich
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Kalbe Farma Tbk PT

+ Add to Watchlist

LCLA:GR

0.109 EUR 0.001 0.91%

As of 13:54:48 ET on 08/29/2014.

Snapshot for Kalbe Farma Tbk PT (LCLA)

Open: 0.109 Day's Range: 0.102 - 0.109 Volume: 0
Previous Close: 0.110 52wk Range: 0.063 - 0.119 1-Yr Rtn: +32.84%

Stock Chart for LCLA

No chart data available.
  • LCLA:GR 0.109
  • 1D
  • 1M
  • 1Y
0.110
Interactive LCLA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LCLA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 35.5687
Relative P/E vs. DAX -
Earnings Per Share (IDR) (ttm) -
Est. EPS (IDR) (12/2014) 47.1510
Est. PEG Ratio 3.1037
Market Cap (M EUR) 5,109.39
Shares Outstanding (M) 46,875.12
30 Day Average Volume 1,838
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 0.97%
Cash Dividend (IDR) 17.0000
Dividend Ex-Date 06/16/2014
5 Year Dividend Growth 42.80%
Next Earnings Announcement 10/28/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LCLA

  • Revenue
  • Net Income (M/IDR)
  • Profit Margin (%)

Company Profile & Key Executives for LCLA

PT Kalbe Farma Tbk produces and develops pharmaceutical products for human and animal healthcare. Through its subsidiaries, the Company also operates in the pharmaceutical, health food, and packaging industries.

Johannes SetijonoPresident CommissionerBernadette Ruth Irawaty SetiadyPresident Director
Budi Dharma WreksoatmodjoVice President DirectorVidjongtius VidjongtiusCFO/Director/Secretary
More Company Profile & Key Executives for LCLA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil